FI20040359A0 - Menetelmä vatsan limakalvon tilan ennustamiseksi - Google Patents

Menetelmä vatsan limakalvon tilan ennustamiseksi

Info

Publication number
FI20040359A0
FI20040359A0 FI20040359A FI20040359A FI20040359A0 FI 20040359 A0 FI20040359 A0 FI 20040359A0 FI 20040359 A FI20040359 A FI 20040359A FI 20040359 A FI20040359 A FI 20040359A FI 20040359 A0 FI20040359 A0 FI 20040359A0
Authority
FI
Finland
Prior art keywords
gastric mucosa
data
subject
belonging
probability
Prior art date
Application number
FI20040359A
Other languages
English (en)
Swedish (sv)
Other versions
FI119572B (fi
FI20040359A (fi
Inventor
Seppo Sarna
Tapani Tiusanen
Osmo Suovaniemi
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Publication of FI20040359A0 publication Critical patent/FI20040359A0/fi
Priority to FI20040359A priority Critical patent/FI119572B/fi
Priority to ES05717315T priority patent/ES2325170T3/es
Priority to CNA2005800142478A priority patent/CN1950704A/zh
Priority to AT05717315T priority patent/ATE430938T1/de
Priority to JP2007501300A priority patent/JP4814212B2/ja
Priority to US10/598,606 priority patent/US20080162101A1/en
Priority to PL05717315T priority patent/PL1725876T3/pl
Priority to DE602005014345T priority patent/DE602005014345D1/de
Priority to PCT/FI2005/050061 priority patent/WO2005085871A1/en
Priority to EP05717315A priority patent/EP1725876B1/en
Publication of FI20040359A publication Critical patent/FI20040359A/fi
Application granted granted Critical
Publication of FI119572B publication Critical patent/FI119572B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G01N2333/96475—Aspartic endopeptidases (3.4.23) with definite EC number
    • G01N2333/96477—Pepsin (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
FI20040359A 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi FI119572B (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20040359A FI119572B (fi) 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi
JP2007501300A JP4814212B2 (ja) 2004-03-05 2005-03-03 胃粘膜の状態を予測するための方法
CNA2005800142478A CN1950704A (zh) 2004-03-05 2005-03-03 一种预测胃粘膜状态的方法
AT05717315T ATE430938T1 (de) 2004-03-05 2005-03-03 Verfahren zur vorhersage des zustands der magenschleimhaut
ES05717315T ES2325170T3 (es) 2004-03-05 2005-03-03 Un metodo para predecir el estado de la mucosa gastrica.
US10/598,606 US20080162101A1 (en) 2004-03-05 2005-03-03 Method for Predicting the State of the Gastric Mucosa
PL05717315T PL1725876T3 (pl) 2004-03-05 2005-03-03 Sposób przewidywania stanu śluzówki żołądka
DE602005014345T DE602005014345D1 (de) 2004-03-05 2005-03-03 Leimhaut
PCT/FI2005/050061 WO2005085871A1 (en) 2004-03-05 2005-03-03 A method for predicting the state of the gastric mucosa
EP05717315A EP1725876B1 (en) 2004-03-05 2005-03-03 A method for predicting the state of the gastric mucosa

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20040359 2004-03-05
FI20040359A FI119572B (fi) 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi

Publications (3)

Publication Number Publication Date
FI20040359A0 true FI20040359A0 (fi) 2004-03-05
FI20040359A FI20040359A (fi) 2005-09-06
FI119572B FI119572B (fi) 2008-12-31

Family

ID=32039385

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040359A FI119572B (fi) 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi

Country Status (10)

Country Link
US (1) US20080162101A1 (fi)
EP (1) EP1725876B1 (fi)
JP (1) JP4814212B2 (fi)
CN (1) CN1950704A (fi)
AT (1) ATE430938T1 (fi)
DE (1) DE602005014345D1 (fi)
ES (1) ES2325170T3 (fi)
FI (1) FI119572B (fi)
PL (1) PL1725876T3 (fi)
WO (1) WO2005085871A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011501177A (ja) * 2007-10-26 2011-01-06 ビオヒット・ユルキネン・オサケユキテュア 自己免疫疾患および萎縮性胃炎と関連する胃癌を診断するための方法および製品
WO2011161301A1 (en) * 2010-06-24 2011-12-29 Valtion Teknillinen Tutkimuskeskus State inference in a heterogeneous system
JP2014517279A (ja) 2011-05-10 2014-07-17 ネステク ソシエテ アノニム 個別治療管理のための疾患活動性プロファイリングの方法
AU2018277256A1 (en) 2017-05-31 2020-01-30 Prometheus Biosciences, Inc. Methods for assessing mucosal healing in Crohn's disease patients
CN112002414B (zh) * 2020-08-23 2024-01-26 吾征智能技术(北京)有限公司 一种基于胃液认知胃病的系统、设备、存储介质
CN113466471B (zh) * 2021-09-06 2021-11-26 中国农业科学院农产品加工研究所 胃粘膜损伤相关生物标志物、筛选方法及用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0746111B2 (ja) * 1988-03-18 1995-05-17 株式会社日立製作所 試料分析方法及びこれを用いた自動分析装置
US6861510B1 (en) * 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
JP2949474B2 (ja) * 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
JP2000270897A (ja) * 1999-03-23 2000-10-03 Mitsubishi Kagaku Bio-Clinical Laboratories Inc トランスフォーミング増殖因子β１の遺伝子多型による骨粗鬆症危険因子の検出法
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
WO2001077685A2 (en) * 2000-04-10 2001-10-18 The General Hospital Corporation Diagnosis and treatment of gastrointestinal disease
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
FI20011908A (fi) * 2001-09-28 2003-03-29 Biohit Oyj Menetelmä vatsasyövän osoittamiseksi
SE0200974D0 (sv) * 2002-03-27 2002-03-27 Phagen Ab Screening method for gastritis
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
US6950544B2 (en) * 2003-02-14 2005-09-27 Virtualscopics, Llc Automated measurement of anatomical structures in medical imaging

Also Published As

Publication number Publication date
ATE430938T1 (de) 2009-05-15
FI119572B (fi) 2008-12-31
PL1725876T3 (pl) 2009-10-30
CN1950704A (zh) 2007-04-18
WO2005085871A1 (en) 2005-09-15
ES2325170T3 (es) 2009-08-27
JP4814212B2 (ja) 2011-11-16
EP1725876B1 (en) 2009-05-06
JP2007526470A (ja) 2007-09-13
DE602005014345D1 (de) 2009-06-18
EP1725876A1 (en) 2006-11-29
FI20040359A (fi) 2005-09-06
US20080162101A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
WO2002054084A8 (en) A method for diagnosing atrophic gastritis
Zhang et al. Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing
DE602004012974D1 (de) Abtastungverfahren und -vorrichtung zur abtastung von korrosion und oberflächenfehlern
DE602005014345D1 (de) Leimhaut
HK1248311B (zh) 預測死亡率及檢測重症疾病
NO20070611L (no) Resekvensering av patogene mikroarray.
WO2006126008A3 (en) Improved immunoassay methods
RU2009101049A (ru) Повышенная специфичность детектирования анализируемого вещества путем измерения связанных и не связанных меток
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
ATE415623T1 (de) Verfahren und vorrichtung zur messung der aktivierung von neutrophilen zellen
WO2021076036A1 (en) Apparatuses and methods for detection of pancreatic cancer
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
RU2011140471A (ru) Способ диагностики эндометриоза и диагностический набор для эндометриоза
JP2020514689A5 (fi)
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
Chen et al. The early detection of immunoglobulins via optical-based lateral flow immunoassay platform in COVID-19 pandemic
Hanaoka et al. Clinical significance of the highly sensitive fucosylated fraction of α‐fetoprotein in patients with chronic liver disease
Sousa et al. Advances on diagnosis of Helicobacter pylori infections
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
EA200500449A1 (ru) Способ выявления риска развития у субъекта заболевания, связанного с кислотой
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
WO2020247952A2 (en) Systems comprising substrates and methods of using the same for detection of pancreatic cancers